These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9526414)

  • 41. Perioperative blood and blood component therapy.
    Irving GA
    Can J Anaesth; 1992 Dec; 39(10):1105-15. PubMed ID: 1464138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood management in total joint arthroplasty.
    Sculco TP; Baldini A; Keating EM
    Instr Course Lect; 2005; 54():51-66. PubMed ID: 15948435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-dose epoetin alfa reduces blood transfusions compared with autologous donation.
    Hardwick ME; Morris BM; Colwell CW
    Clin Orthop Relat Res; 2004 Jun; (423):240-4. PubMed ID: 15232456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study.
    Lasocki S; Krauspe R; von Heymann C; Mezzacasa A; Chainey S; Spahn DR
    Eur J Anaesthesiol; 2015 Mar; 32(3):160-7. PubMed ID: 25564780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature.
    Moonen AF; Neal TD; Pilot P
    Injury; 2006 Dec; 37 Suppl 5():S11-6. PubMed ID: 17338906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit.
    Kumar A; Dimov V
    Cleve Clin J Med; 2006 Sep; 73 Electronic Suppl 1():S13-5. PubMed ID: 17019750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. When to administer modified blood products.
    Fitzpatrick L
    Nursing; 2002 May; 32(5):36-41; quiz 42. PubMed ID: 12035651
    [No Abstract]   [Full Text] [Related]  

  • 48. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
    Faris PM; Ritter MA
    Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perioperative Allogeneic Red Blood-Cell Transfusion Associated with Surgical Site Infection After Total Hip and Knee Arthroplasty.
    Everhart JS; Sojka JH; Mayerson JL; Glassman AH; Scharschmidt TJ
    J Bone Joint Surg Am; 2018 Feb; 100(4):288-294. PubMed ID: 29462032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty.
    Bou Monsef J; Buckup J; Waldstein W; Cornell C; Boettner F
    Arch Orthop Trauma Surg; 2014 Jan; 134(1):53-8. PubMed ID: 24190654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How to improve perioperative blood management in patients undergoing total hip or knee replacement surgery?].
    Oberhofer D; Sakić K; Janković S; Tonković D; Vrgoc G
    Lijec Vjesn; 2012; 134(11-12):322-7. PubMed ID: 23401978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative orthopaedic blood salvage and reinfusion.
    Arlington RG; Costigan KA; Aievoli CP
    Orthop Nurs; 1992; 11(3):30-8. PubMed ID: 1625912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood component replacement therapy.
    Coffland FI; Sheleton DM
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):543-56. PubMed ID: 8217049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia.
    Borghi B; Casati A
    Eur J Anaesthesiol; 2000 Jul; 17(7):411-7. PubMed ID: 10964142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations.
    Muñoz M; García-Erce JA; Villar I; Thomas D
    Vox Sang; 2009 Jan; 96(1):1-13. PubMed ID: 19121192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can an Arthroplasty Registry Help Decrease Transfusions in Primary Total Joint Replacement? A Quality Initiative.
    Markel DC; Allen MW; Zappa NM
    Clin Orthop Relat Res; 2016 Jan; 474(1):126-31. PubMed ID: 26215083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
    Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
    Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current and future trends in transfusion therapy.
    Rossetto CL; McMahon JE
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):160-73. PubMed ID: 10944864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
    Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
    Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation of a total joint replacement-focused perioperative surgical home: a management case report.
    Garson L; Schwarzkopf R; Vakharia S; Alexander B; Stead S; Cannesson M; Kain Z
    Anesth Analg; 2014 May; 118(5):1081-9. PubMed ID: 24781576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.